References
- NIOSH Alert, Preventing Occupational Exposures to Antineoplastic and Other Hazardous Drugs in Healthcare Settings (NIOSH - National Institute for Occupational Safety and Health, Cincinnati, OH, USA, 2004).
- T.H. Connor and M.A. McDiarmid, CA Cancer J. Clin 56, 354 (2006). doi:https://doi.org/10.3322/canjclin.56.6.354.
- W. Fransman, R. Vermeulen and H. Kromhout, Int. Arch. Occup. Environ. Health 78, 403 (2005). doi:https://doi.org/10.1007/s00420-004-0595-1.
- L.A. Power and J.W. Coyne, Am. J. Health-Syst. Pharm 75, 1996 (2018). doi:https://doi.org/10.2146/ajhp180564.
- P.M. Lancharro, N. De Castro-Acuña Iglesias, F.J. González-Barcala and J.D. Moure González, Farm. Hosp 40, 604 (2016). doi:https://doi.org/10.7399/fh.2016.40.6.9103.
- A. Janes, C. Tanguay, N.J. Caron and J.F. Bussières, Can. J. Hosp. Pharm 68, 279 (2015). doi:https://doi.org/10.4212/cjhp.v68i4.1467.
- P.J. Sessink, T.H. Connor, J.A. Jorgenson and T.G. Tyler, J. Oncol. Pharm. Pract 17, 39 (2011). doi:https://doi.org/10.1177/1078155210361431.
- S. Viegas, M. Pádua, A.C. Veiga, E. Carolino and M. Gomes, Environ. Monit. Assess. 186, 7807 (2014). doi:https://doi.org/10.1007/s10661-014-3969-1.
- T.H. Connor, M.D. Zock and A.H. Snow, J. Occup. Environ. Hyg 13, 658 (2016). doi:https://doi.org/10.1080/15459624.2016.1165912.
- P. Marie, C. Christophe, R. Manon, M. Marc, B. Charleric and V. Patrice, Environ. Monit. Assess. 189, 2 (2017). doi:https://doi.org/10.1007/s10661-016-5762-9.
- A.W. Buning, T.H. Geersing and M. Crul, Int. J. Pharm. Pract 28, 66 (2020). doi:https://doi.org/10.1111/ijpp.12575.
- R.R. Larson, M.B. Khazaeli and H.K. Dillon, Am. J. Health-Syst. Pharm 59, 270 (2002). doi:https://doi.org/10.1093/ajhp/59.3.270.
- S. Valero-García, E. González-Haba, M.Q. Gorgas-Torner, J.M. Alonso-Herreros, A.C. Cercós Lletí, J.L. Poveda-Andrés, M.Á. Calleja-Hernandez and O. Delgado-Sánchez, Farm Hosp. 45, 2 (2021). doi:https://doi.org/10.7399/fh.11655.
- S. Nussbaumer, L. Geiser, F. Sadeghipour, D. Hochstrasser, P. Bonnabry, J.L. Veuthey and S. Fleury-Souverain, Anal. Bioanal. Chem 402, 2499 (2012). doi:https://doi.org/10.1007/s00216-011-5157-2.
- R. Schierl, C. Masini, S. Groeneveld, E. Fischer, A. Böhlandt, V. Rosini and D. Paolucci, J. Oncol. Pharm. Pract 22, 37 (2016). doi:https://doi.org/10.1177/1078155214551316.
- E. Ziegler, H.J. Mason and P.J. Baxter, Occup. Environ. Med 59, 608 (2002). doi:https://doi.org/10.1136/oem.59.9.608.
- USP <797> Pharmaceutical Compounding - Sterile Preparations. (2004).
- R. Schierl, A. Böhlandt and D. Nowak, Ann. Occup. Hyg. 53, 703 (2009). doi:https://doi.org/10.1093/annhyg/mep050.
- P.J. Sessink, 2011. Environmental Contamination with Cytostatic Drugs: Past, Present and Future.
- T.K. Kiffmeyer, J. Tuerk, M. Hahn, H. Stuetzer, C. Hadstein, A. Heinemann and U. Eixkmann, Ann. Occup. Hyg. 57, 444 (2013). doi:https://doi.org/10.1093/annhyg/mes081.
- USP General Chapter <800> Hazardous Drugs – Handling in Healthcare Settings. (2020) .
- G. Schmaus, R. Schierl and S. Funck, Am. J. Health Syst. Pharm 59, 956 (2002). doi:https://doi.org/10.1093/ajhp/59.10.956.
- L. Sabatini, A. Barbieri, M. Tosi and F.S. Violante, J. Mass. Spectrom 40, 669 (2005). doi:https://doi.org/10.1002/jms.840.
- C. Sottani, R. Turci, R. Schierl, R. Gaggeri, A. Barbieri, F.S. Violante and C. Minoia, Mass. Spectrom 21, 1289 (2007).
- J. Tuerk, T.K. Kiffmeyer, C. Hadtstein, A. Heinemann, H. Moritz, H. Stuetzer, H.M. Kuss and U. Eickmann, Intern. J. Environ. Anal. Chem 91, 1178 (2011). doi:https://doi.org/10.1080/03067319.2010.494769.
- A. Acramel, T. Chouquet, A. Plé, H. Sauvageon, S. Mourah, F. Jouenne and L. Goldwirt, Rapid Commun. Mass Spectrom. 34, e8594 (2020). doi:https://doi.org/10.1002/rcm.8594.
- S. Nussbaumer, S. Fleury-Souverain, P. Antinori, F. Sadeghipour, D.F. Hochstrasser, P. Bonnabry, J.L. Veuthey and L. Geiser, Anal. Bioanal. Chem 398, 3033 (2010). doi:https://doi.org/10.1007/s00216-010-4243-1.
- M. Jeronimo, M. Colombo, G. Astrakianakis and C.Y. Hon, Anal. Bioanal. Chem 407, 7083 (2015). doi:https://doi.org/10.1007/s00216-015-8868-y.
- EMA, European Medicines Agency. Guideline on Bioanalytical Method Validation. (2012).